Italian study tracks Real-World treatment of painful uterine condition

NCT ID NCT07478614

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 200 women aged 20-50 with adenomyosis, a condition causing pelvic pain and heavy bleeding. Researchers will observe which treatments doctors prescribe and how well they work over 12 months. The goal is to understand current medical practices and help develop better treatment guidelines.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help create clearer guidelines for treating adenomyosis, improving care and quality of life for affected women.

What could go wrong

This is an observational study, not testing a new treatment. It only describes current practices, so it won't directly lead to a cure or new therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS OF UTERUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenomyosis Dysmenorrhea female reproductive system disorder Menorrhagia uterine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ospedale San Carlo

    RECRUITING

    Potenza, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••